Skip to content
ARTHEx biotech
  • About us
  • Our products
  • Pipeline
    • Publications
  • Team/Investors
  • Contact/Events
  • News

Latest Publications

Latest publications

The latest publications related to our research work, on advanced RNA treatments against genetic diseases, can be consulted online on this page.

Graphical Abstract

Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy

Cerro-Herreros E, et al. Mol Ther Nucleic Acids. 2020. PMID: 32805487

DOI: https://doi.org/10.1016/j.omtn.2020.07.021

More published works will be inserted in this section in the coming days.

Arthex on Twitter

AvatarARTHEx biotech@Arthexbiotech·

Closer to patients in support of International Myotonic Dystrophy Awareness Day https://arthexbiotech.com/closer-to-patients-in-support-of-international-myotonic-dystrophy-awareness-day/

Retweet on TwitterARTHEx biotech Retweeted
AvatarAdvent France Biotechnology@AdventFrance·

[AFB portfolio] @Arthexbiotech for the International Myotonic Dystrophy Awareness Day on Sept 15th https://twitter.com/Arthexbiotech/status/1432223112377028608

Retweet on TwitterARTHEx biotech Retweeted
AvatarPedroFN@PedroFN20·

@Arthexbiotech #Steiner #dm1 Si eres paciente de distrofia miotónica o estás implicad@ en esta enfermedad, participa en esta encuesta de @Arthexbiotech con motivo del Día Internacional de la distrofia miotónica

Retweet on TwitterARTHEx biotech Retweeted
AvatarScience Animated@Sci_Ani·

How can an #RNA be used to treat #myotonicdystrophy?

@Arthexbiotech is focused on the development of the next generation of RNA therapies for #geneticdiseases

Find out more now:

https://www.youtube.com/watch?v=K3AETZ6MsRI

Load More...

News

  • Más cerca de los pacientes apoyando el Día Mundial de la Distrofia Miotónica: September 14, 2021
  • Closer to patients in support of International Myotonic Dystrophy Awareness Day September 14, 2021
  • Participa en nuestra encuesta sobre el Día Internacional de la Distrofia Miotónica August 27, 2021
  • Take part in our survey on the occasion of the International Day of Awareness on Myotonic Dystrophy August 27, 2021
  • We are delighted to announce a new addition to our growing team, Sheila Soriano May 25, 2021

Logo blanco
Drug discovery in neuromuscular diseases
ARTHEX BIOTECH. S.L
C/ Catedrático Agustín Escardino 9 – 46980 Paterna, Valencia (Spain)
Telephone: +34 625 016 629 – E-mail:  info@arthexbiotech.com
Linkedin   Facebook   Twitter
******************

FUNDING

******************

© 2021 ARTHEx biotech • Built with GeneratePress
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read MoreACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT